Left atrial appendage as a target for reducing strokes: Justifiable rationale? Safe and effective approaches?

Heart Rhythm

Volumn 8, Issue 2, 2011, Pages 194-198

  Syed, Faisal F ^a   Asirvatham, Samuel J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ANATOMY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; LEFT HEART ATRIUM APPENDAGE; LIGATION; NOTE; PHYSIOLOGY; PRIORITY JOURNAL; STROKE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 79251613004     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.11.022     Document Type: Editorial

References (44)

1. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 7 2006 e257 e354
2. J.L. Blackshear, and J.A. Odell Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation Ann Thorac Surg 61 1996 755 759
3. J.A. Odell, J.L. Blackshear, and E. Davies Thoracoscopic obliteration of the left atrial appendage: potential for stroke reduction? Ann Thorac Surg 61 1996 565 569
4. S. Schulman Clinical practice Care of patients receiving long-term anticoagulant therapy N Engl J Med 349 2003 675 683
5. T.J. Bungard, M.L. Ackman, G. Ho, and R.T. Tsuyuki Adequacy of anticoagulation in patients with atrial fibrillation coming to a hospital Pharmacotherapy 20 2000 1060 1065
6. K. Bartus, J. Bednarek, and J. Myc Feasibility of closed-chest ligation of the left atrial appendage in humans Heart Rhythm 8 2011 188 193
7. A. Harloff, M. Handke, M. Reinhard, A. Geibel, and A. Hetzel Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke Stroke 37 2006 859 864
8. J. Bogousslavsky, G. Van Melle, F. Regli, and L. Kappenberger Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation: the Lausanne Stroke Registry Neurology 40 1990 1046 1050
9. V.T. Miller, J.F. Rothrock, L.A. Pearce, W.M. Feinberg, R.G. Hart, and D.C. Anderson Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism Stroke Prevention in Atrial Fibrillation Investigators Neurology 43 1993 32 36
10. R.G. Hart, L.A. Pearce, and V.T. Miller Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies Cerebrovasc Dis 10 2000 39 43
11. M.I. Chimowitz, M.J. Lynn, and H. Howlett-Smith Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis N Engl J Med 352 2005 1305 1316
12. R.O. Bonow, B.A. Carabello, and K. Chatterjee 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation 118 2008 e523 e661
13. M.A. Garcia-Fernandez, E. Perez-David, and J. Quiles Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study J Am Coll Cardiol 42 2003 1253 1258
14. Dawson AG, Asopa S, Dunning J. Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? Interact Cardiovasc Thorac Surg;10:306311.
15. J.S. Healey, E. Crystal, and A. Lamy Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke Am Heart J 150 2005 288 293
16. E.S. Katz, T. Tsiamtsiouris, R.M. Applebaum, A. Schwartzbard, P.A. Tunick, and I. Kronzon Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiographic study J Am Coll Cardiol 36 2000 468 471
17. D.R. Holmes Jr., and R. Fountain Stroke prevention in atrial fibrillation: WATCHMAN versus warfarin Expert Rev Cardiovasc Ther 7 2009 727 729
18. J.L. Blackshear, W.D. Johnson, and J.A. Odell Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation J Am Coll Cardiol 42 2003 1249 1252
19. S.H. Ostermayer, M. Reisman, and P.H. Kramer Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials J Am Coll Cardiol 46 2005 9 14
20. G.P. Ussia, S. Mangiafico, and A. Privitera Percutaneous left atrial appendage transcatheter occlusion in patients with chronic nonvalvular atrial fibrillation: early institutional experience J Cardiovasc Med (Hagerstown) 7 2006 569 572
21. J.W. Park, B. Leithauser, U. Gerk, M. Vrsansky, and F. Jung Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes J Invasive Cardiol 21 2009 446 450
22. P.C. Block, S. Burstein, and P.N. Casale Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study JACC Cardiovasc Interv 2 2009 594 600
23. B. Meier, I. Palacios, and S. Windecker Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation Catheter Cardiovasc Interv 60 2003 417 422
24. Park JW, Bethencourt A, Sievert H, et al. Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv [Epub ahead of print].
25. D.R. Holmes, V.Y. Reddy, and Z.G. Turi Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 9689 2009 534 542
26. R.B. Fountain, D.R. Holmes, and K. Chandrasekaran The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial Am Heart J 151 2006 956 961
27. V.J. DiSesa, S. Tam, and L.H. Cohn Ligation of the left atrial appendage using an automatic surgical stapler Ann Thorac Surg 46 1988 652 653
28. P.A. Friedman, S.J. Asirvatham, and C. Dalegrave Percutaneous epicardial left atrial appendage closure: preliminary results of an electrogram guided approach J Cardiovasc Electrophysiol 20 2009 Aug 908 915
29. C.J. Bruce, C.M. Stanton, and S.J. Asirvatham Percutaneous epicardial left atrial appendage closure: intermediate-term results J Cardiovasc Electrophysiol 2010 Jul 19.[Epub ahead of print].
30. R.J. Lee, K. Bartus, and S.J. Yakubov Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine model Circ Cardiovasc Interv 3 2010 224 229
31. S.M. Singh, S.R. Dukkipati, A. d'Avila, S.K. Doshi, and V.Y. Reddy Percutaneous left atrial appendage closure with an epicardial suture ligation approach: a prospective randomized pre-clinical feasibility study Heart Rhythm 7 2010 370 376
32. S.J. Asirvatham Methods to identify the pulmonary vein ostium Heart Rhythm 2 2005 1090 1093
33. S.J. Asirvatham Pulmonary vein-related maneuvers: part I Heart Rhythm 4 2007 538 544
34. S.J. Asirvatham Pacing maneuvers for nonpulmonary vein sources: part II Heart Rhythm 4 2007 681 685
35. N.M. Al-Saady, O.A. Obel, and A.J. Camm Left atrial appendage: structure, function, and role in thromboembolism Heart 82 1999 547 554
36. E.K. Heist, M. Refaat, S.B. Danik, G. Holmvang, J.N. Ruskin, and M. Mansour Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation Heart Rhythm 3 2006 1313 1318
37. P. Su, K.P. McCarthy, and S.Y. Ho Occluding the left atrial appendage: anatomical considerations Heart 94 2008 1166 1170
38. J.P. Veinot, P.J. Harrity, and F. Gentile Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination Circulation 96 1997 3112 3115
39. P.Y. Pennec, Y. Jobic, J.J. Blanc, E. Bezon, and J.A. Barra Assessment of different procedures for surgical left atrial appendage exclusion Ann Thorac Surg 76 2003 2168 2169
40. S.J. Asirvatham The isolated appendage: a new victim of collateral damage during atrial fibrillation ablation? Heart Rhythm 7 2010 181 183
41. C.P. Chan, W.S. Wong, and S. Pumprueg Inadvertent electrical isolation of the left atrial appendage during catheter ablation of persistent atrial fibrillation Heart Rhythm 7 2010 173 180
42. G.W. Albers, H.C. Diener, and L. Frison Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial JAMA 293 2005 690 698
43. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
44. L. Wallentin, S. Yusuf, and M.D. Ezekowitz Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Lancet 376 9745 2010 975 983